As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
infectiousdiseaseadvisor.com15h
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
S&P 500 Gains and Losses Today: Electronic Arts Drops as Game Maker Cuts Forecast
The S&P 500 gained 0.5% on Thursday, Jan. 23, reaching a record close as President Donald Trump pressed for lower oil prices ...
Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
MRNA’s first problem is the lack of near-term catalysts beyond infectious disease vaccines. The stock often swings on disease outbreaks, such as H5N1 avian flu last year, but this is unlikely to ...
Scientific American11h
The Latest on Bird Flu in Humans, Cats and Chickens
H5N1 avian influenza continues to spread amid commercial and backyard poultry, and additional cases have been reported in ...
Possible evidence of bird flu vaccinations driving virus evolution
A team of virologists, infectious disease specialists and pathobiologists affiliated with several institutions in China and ...
Dow Jones Today: Stocks Surge in Late Trading to Extend Winning Streak; S&P 500 Hits Record Closing High
Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.